Syntheses of 5‐(2‐radiohaloethyl)‐ and 5‐(2‐radiohalovinyl)‐2′‐ deoxyuridines. Novel types of radiotracer for monitoring cancer gene therapy with PET
- 17 March 2003
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 46 (5) , 421-439
Abstract
Syntheses of 5‐(2‐[18F]fluoroethyl)‐ (1), 5‐(2‐[80Br]bromoethyl)‐ (2), un‐deprotected (E)‐5‐(2‐[18F]fluorovinyl)‐ (3) and (E)‐5‐(2‐[80Br]bromovinyl)‐2′‐deoxyuridines (4) as the tracers for monitoring cancer gene therapy with positron emission tomography were described. Decay corrected radiochemical yield and synthesis time including labeling and HPLC purification from end of bombardment for 1 was 9.5% and 2 hours, respectively; yield and time for 2 was 16% and 2 hours, respectively. Chemical (approximate to radiochemical) yield and time for synthesis of 3 was 7.5% and 7 minutes, respectively. Radiochemical yield and synthesis time including labeling and HPLC purification of an analytical sample of 4 was 60% and 30 minutes, respectively. Both 2 and 4 received the side reactions during HPLC purification, i.e. ring closure and cleavage of glycosidic bond, respectively. Application of 2 and 4 needed to be confirmed by in vitro or in vivo experiments. Radiochemical yield of 1 could be optimized by employing a modified protocol for preparation of its precursor. The preparation of fluorovinyl counterparts had demonstrated the potential utility of the stannane, 3‐tolyl‐3′,5′‐di‐O‐acetyl‐(E)‐5‐(2‐stannylvinyl)‐2′‐deoxyuridine 7. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 28 references indexed in Scilit:
- Synthesis of [18F]‐labeled 2′‐deoxy‐2′‐fluoro‐5‐methyl‐1‐β‐D‐arabinofuranosyluracil ([18F]‐FMAU)Journal of Labelled Compounds and Radiopharmaceuticals, 2002
- Synthesis of 1-(2-deoxy-?-D-ribofuranosyl)-2,4- difluoro-5-(2-halo-1-hydroxyethyl)benzenes and related derivatives: ?thymine replacement? analogs of deoxythymidine for evaluation as antiviral and anticancer agentsDrug Development Research, 2001
- Synthesis of 8-[18F]fluoroguanine derivatives: in vivo probes for imaging gene expression with positron emission tomographyNuclear Medicine and Biology, 2000
- Synthesis of 4-O-Methyl-Protected 5-(2-Hydroxyethyl)-2′-deoxyuridine Derivatives and their Nucleophilic Fluorination to 5-(2-Fluoroethyl)-2′-deoxyuridineSynthesis, 1999
- Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: Synthesis and in vitro evaluation of 9-{3-[18F] Fluoro-1-hydroxy-2-propoxymethyl guanineBioorganic & Medicinal Chemistry Letters, 1997
- Synthesis of 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): A potential imaging agent of viral infection and gene therapy using PETNuclear Medicine and Biology, 1996
- Synthesis of (E)-5-(2-cIOdovinyl)-3′-0-(1-Methyl-1,4-Dihydropyridyl-3 -Carbonyl)-2′-Fluoro-2′-Deoxyuridine (Ivfru-Cds) for Brain Targetted Delivery of Ivfru, an Antiviral NucleosideNucleosides and Nucleotides, 1993
- Synthesis of brain‐targeted 5‐iodo‐, 5‐vinyl‐ and (E)‐5‐(2‐iodovinyl)‐2′‐deoxyuridines coupled to a dihydropyridine ⇌ pyridinium salt redox chemical delivery systemJournal of Heterocyclic Chemistry, 1991
- 2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activityJournal of Medicinal Chemistry, 1987
- Fluorination of aromatic compounds with F2 and acetyl hypofluorite: synthesis of 18F-aryl fluorides by cleavage of aryl-tin bonds [1]Journal of Fluorine Chemistry, 1984